Number needed to treat (NNT): estimation of a measure of clinical benefit
- 20 December 2001
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 20 (24), 3947-3962
- https://doi.org/10.1002/sim.1173
Abstract
The number needed to treat (NNT) is becoming increasingly popular as an index for reporting the results of randomized trials and other clinical studies. It represents the expected number of patients who must be treated with an experimental therapy in order to prevent one additional adverse outcome event (or, depending on the context, to expect one additional beneficial outcome), compared to the expected event rates under the control therapy. Although NNT is a clinically useful measure, little work has been done on its statistical properties. In this paper, alternative NNT-type measures are defined for use with discrete or continuous data. Estimators and their variances are obtained for these measures in cross-over or parallel group designs. The ideas are illustrated with data on quality of life in asthma patients. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Estimating the number needed to treat (NNT) index when the data are subject to errorStatistics in Medicine, 2001
- Disease impact number and population impact number: population perspectives to measures of risk and benefit Commentary: DINS, PINS, and things---clinical and population perspectives on treatment effectsBMJ, 2000
- Number Needed to Treat: Properties and ProblemsJournal of the Royal Statistical Society Series A: Statistics in Society, 2000
- Assessing the minimal important difference in symptoms: A comparison of two techniquesJournal of Clinical Epidemiology, 1996
- ‘Unqualified Success’ and ‘Unmitigated Failure’ Number-Needed-to-Treat-Related Concepts for Assessing Treatment Efficacy in the Presence of Treatment-Induced Adverse EventsInternational Journal of Epidemiology, 1996
- The number needed to treat: a clinically useful nomogram in its proper contextBMJ, 1996
- Understanding clinical trialsBMJ, 1994
- Ischemic heart disease prevention: Estimating the impact of interventionsJournal of Clinical Epidemiology, 1992
- Measurement of health statusControlled Clinical Trials, 1989
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988